Home/Pipeline/Therapy for Pediatric NEC

Therapy for Pediatric NEC

Pediatric Necrotizing Enterocolitis

UnknownActive

Key Facts

Indication
Pediatric Necrotizing Enterocolitis
Phase
Unknown
Status
Active
Company

About INCELL

INCELL operates as a hybrid products manufacturer and contract development and manufacturing organization (CDMO) in the regenerative medicine space. The company leverages its GMP capabilities to support both its own therapeutic programs and external clients, with a focus on cell culture media, transport solutions, and proprietary cell lines. Through a strategic alliance with 4RMED LLC, INCELL manages clinical development for programs targeting conditions like ALS, pneumonia, and pediatric necrotizing enterocolitis. Its business model integrates product sales, contract services, and internal therapeutic development.

View full company profile